Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| SARS Virus | 12 | 2020 | 13021 | 0.55 | Why? |
| Cyclophilins | 1 | 2011 | 76 | 0.44 | Why? |
| Virulence Factors | 1 | 2009 | 338 | 0.32 | Why? |
| Sequence Deletion | 2 | 2009 | 674 | 0.30 | Why? |
| Membrane Glycoproteins | 6 | 2012 | 2273 | 0.28 | Why? |
| Severe Acute Respiratory Syndrome | 4 | 2020 | 12361 | 0.28 | Why? |
| Viral Tropism | 2 | 2020 | 1329 | 0.23 | Why? |
| Viral Envelope Proteins | 6 | 2012 | 3539 | 0.23 | Why? |
| Cytarabine | 1 | 2020 | 64 | 0.21 | Why? |
| Coronavirus 229E, Human | 1 | 2009 | 1241 | 0.21 | Why? |
| Antimetabolites, Antineoplastic | 1 | 2020 | 99 | 0.20 | Why? |
| Chiroptera | 3 | 2010 | 3530 | 0.20 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.20 | Why? |
| Multigene Family | 1 | 2020 | 377 | 0.19 | Why? |
| Coronavirus | 5 | 2020 | 18339 | 0.19 | Why? |
| Automation | 1 | 2021 | 429 | 0.18 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 290 | 0.18 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.16 | Why? |
| Cornea | 1 | 2021 | 410 | 0.16 | Why? |
| Germany | 6 | 2021 | 9196 | 0.15 | Why? |
| Th17 Cells | 1 | 2021 | 657 | 0.15 | Why? |
| Influenza B virus | 1 | 2021 | 815 | 0.14 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2021 | 13720 | 0.14 | Why? |
| Autopsy | 3 | 2020 | 3495 | 0.14 | Why? |
| Viral Proteins | 2 | 2011 | 7370 | 0.14 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2020 | 676 | 0.13 | Why? |
| Molecular Sequence Data | 2 | 2009 | 3198 | 0.13 | Why? |
| Viremia | 1 | 2021 | 1020 | 0.13 | Why? |
| Ozone | 1 | 2021 | 757 | 0.12 | Why? |
| Two-Hybrid System Techniques | 1 | 2011 | 116 | 0.12 | Why? |
| RNA, Viral | 8 | 2021 | 32276 | 0.11 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.11 | Why? |
| Jurkat Cells | 1 | 2011 | 273 | 0.11 | Why? |
| Asparagine | 1 | 2010 | 83 | 0.11 | Why? |
| Disinfectants | 1 | 2021 | 1077 | 0.11 | Why? |
| Virus Replication | 5 | 2014 | 14331 | 0.11 | Why? |
| Sequence Analysis, DNA | 2 | 2009 | 2830 | 0.10 | Why? |
| Caco-2 Cells | 2 | 2011 | 1236 | 0.10 | Why? |
| Mannose-Binding Lectin | 1 | 2010 | 131 | 0.10 | Why? |
| Chromosomes, Artificial, Bacterial | 1 | 2009 | 56 | 0.10 | Why? |
| Serologic Tests | 2 | 2021 | 4359 | 0.10 | Why? |
| Protein Interaction Mapping | 1 | 2011 | 487 | 0.10 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.09 | Why? |
| Influenza A virus | 1 | 2021 | 2234 | 0.09 | Why? |
| Membrane Microdomains | 1 | 2008 | 51 | 0.09 | Why? |
| Virus Internalization | 4 | 2012 | 7921 | 0.09 | Why? |
| Cell Line | 7 | 2020 | 12040 | 0.09 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.09 | Why? |
| Phylogeny | 3 | 2020 | 13341 | 0.09 | Why? |
| Cyclosporine | 1 | 2011 | 449 | 0.09 | Why? |
| Disinfection | 1 | 2021 | 2912 | 0.08 | Why? |
| Molecular Diagnostic Techniques | 2 | 2021 | 4239 | 0.08 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.08 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.08 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2021 | 11367 | 0.08 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 2426 | 0.08 | Why? |
| Evolution, Molecular | 1 | 2020 | 3691 | 0.08 | Why? |
| Ghana | 1 | 2009 | 763 | 0.08 | Why? |
| Travel | 2 | 2020 | 7220 | 0.08 | Why? |
| Brain | 2 | 2020 | 5133 | 0.08 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.07 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.07 | Why? |
| Animals | 11 | 2021 | 78931 | 0.07 | Why? |
| Humans | 34 | 2021 | 930598 | 0.07 | Why? |
| Peptidyl-Dipeptidase A | 3 | 2012 | 9659 | 0.07 | Why? |
| Cholesterol | 1 | 2008 | 660 | 0.07 | Why? |
| Vero Cells | 4 | 2021 | 14117 | 0.07 | Why? |
| Mesocricetus | 1 | 2009 | 1847 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.06 | Why? |
| Down-Regulation | 1 | 2009 | 1416 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.06 | Why? |
| Genetic Vectors | 1 | 2009 | 1600 | 0.06 | Why? |
| Virulence | 1 | 2009 | 2172 | 0.06 | Why? |
| Oropharynx | 2 | 2021 | 1581 | 0.06 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.06 | Why? |
| High-Throughput Screening Assays | 2 | 2021 | 1783 | 0.06 | Why? |
| Antiviral Agents | 2 | 2012 | 41703 | 0.06 | Why? |
| Cricetinae | 1 | 2009 | 3344 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Azacitidine | 1 | 2020 | 42 | 0.06 | Why? |
| Leukemia, B-Cell | 1 | 2020 | 50 | 0.05 | Why? |
| Viral Matrix Proteins | 1 | 2009 | 1243 | 0.05 | Why? |
| Host-Pathogen Interactions | 2 | 2011 | 11041 | 0.05 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Neuropathology | 1 | 2020 | 95 | 0.05 | Why? |
| Clone Cells | 1 | 2021 | 312 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Peptides | 1 | 2012 | 2513 | 0.05 | Why? |
| Lung | 3 | 2021 | 31049 | 0.05 | Why? |
| Immunocompetence | 1 | 2021 | 280 | 0.05 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2020 | 393 | 0.05 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.05 | Why? |
| Female | 12 | 2021 | 380317 | 0.05 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.05 | Why? |
| Equipment and Supplies, Hospital | 1 | 2021 | 272 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Coronavirus, Bovine | 1 | 2021 | 289 | 0.05 | Why? |
| Bacteriophages | 1 | 2021 | 268 | 0.04 | Why? |
| HEK293 Cells | 1 | 2011 | 8394 | 0.04 | Why? |
| Corneal Transplantation | 1 | 2021 | 207 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.04 | Why? |
| Automation, Laboratory | 1 | 2020 | 536 | 0.04 | Why? |
| Cadaver | 1 | 2020 | 626 | 0.04 | Why? |
| Cattle | 1 | 2021 | 1336 | 0.04 | Why? |
| Viral Nonstructural Proteins | 1 | 2014 | 4810 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.04 | Why? |
| Bacteria | 1 | 2007 | 1897 | 0.04 | Why? |
| Myeloid Cells | 1 | 2021 | 808 | 0.04 | Why? |
| Adult | 8 | 2021 | 244371 | 0.04 | Why? |
| Feces | 1 | 2009 | 4235 | 0.04 | Why? |
| Glycosylation | 2 | 2010 | 1255 | 0.04 | Why? |
| Protease Inhibitors | 1 | 2011 | 3630 | 0.04 | Why? |
| Archaeal Proteins | 1 | 2014 | 45 | 0.04 | Why? |
| Aged | 10 | 2021 | 215776 | 0.04 | Why? |
| False Positive Reactions | 1 | 2020 | 1338 | 0.04 | Why? |
| Receptors, Virus | 1 | 2012 | 5659 | 0.04 | Why? |
| Serine Endopeptidases | 1 | 2011 | 4606 | 0.04 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Linear Models | 1 | 2020 | 1914 | 0.03 | Why? |
| Pneumonia, Bacterial | 1 | 2021 | 843 | 0.03 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2021 | 2275 | 0.03 | Why? |
| Viruses | 1 | 2007 | 2238 | 0.03 | Why? |
| Bacterial Infections | 1 | 2007 | 2229 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 1439 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| Mutagenesis | 1 | 2014 | 394 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
| Decontamination | 1 | 2021 | 1196 | 0.03 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.03 | Why? |
| Heart | 1 | 2020 | 1791 | 0.03 | Why? |
| Graft Rejection | 1 | 2021 | 1766 | 0.03 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.03 | Why? |
| Exoribonucleases | 1 | 2014 | 455 | 0.02 | Why? |
| Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.02 | Why? |
| Surface Plasmon Resonance | 1 | 2012 | 440 | 0.02 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
| Virus Diseases | 1 | 2007 | 3779 | 0.02 | Why? |
| Golgi Apparatus | 1 | 2009 | 178 | 0.02 | Why? |
| beta-Cyclodextrins | 1 | 2008 | 87 | 0.02 | Why? |
| Blotting, Western | 1 | 2011 | 863 | 0.02 | Why? |
| Methyltransferases | 1 | 2014 | 720 | 0.02 | Why? |
| Mutagenesis, Site-Directed | 1 | 2009 | 449 | 0.02 | Why? |
| Amino Acid Motifs | 1 | 2010 | 620 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.02 | Why? |
| Lectins, C-Type | 1 | 2010 | 405 | 0.02 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.02 | Why? |
| Cell Adhesion Molecules | 1 | 2010 | 472 | 0.02 | Why? |
| Crystallography, X-Ray | 1 | 2014 | 2689 | 0.02 | Why? |
| Protein Interaction Maps | 1 | 2014 | 1333 | 0.02 | Why? |
| Transfection | 1 | 2009 | 864 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Receptors, Cell Surface | 1 | 2010 | 586 | 0.02 | Why? |
| Respiratory Tract Infections | 1 | 2007 | 6817 | 0.02 | Why? |
| Liver | 1 | 2020 | 4007 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Protein Binding | 2 | 2012 | 11430 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Aircraft | 1 | 2007 | 498 | 0.01 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.01 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.01 | Why? |
| Base Sequence | 1 | 2010 | 3581 | 0.01 | Why? |
| Amino Acid Substitution | 1 | 2009 | 1706 | 0.01 | Why? |
| Infant | 2 | 2020 | 30274 | 0.01 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Age Distribution | 1 | 2007 | 3567 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Immunity, Humoral | 1 | 2011 | 4849 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Europe | 1 | 2010 | 12702 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| China | 1 | 2010 | 50654 | 0.00 | Why? |
Pfefferle's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(198)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(207)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_